Statins work best in women

Women with heart disease achieve greater coronary atheroma regression than men with intensive statin therapy, an analysis of a major statin trial shows.

Researchers looked at data from the SATURN trial, which randomised over 1,000 patients with coronary disease to maximal doses of either rosuvastatin or atorvastatin over two years.

Compared with men, women had lower baseline percent atheroma volume (PAV) and yet still demonstrated greater PAV regression following treatment, found the researchers, who include